Report Code: 360-PH 1262
Published Date: Dec 2018
Comparing 12 vendors in Active Pharmaceutical Ingredient (API) across 0 criteria.
Company Profiles
Strategy, financials, growth, and SWOTMarket Insights
Visual quadrant of competitors and leadersBenchmarking
Compare by product, region, and end-userLead Gen Add-on
Use the quadrant to attract clients
FirstWord Pharma
Oct 2026
Investing.com South Africa
Oct 2026
Fierce Biotech
Oct 2026
Endpoints News
Oct 2026
TradingView
Oct 2026
Investing.com
Oct 2026
Fortune
Oct 2026
| ABBVIE INC | North Chicago, Illinois, US | 2013 | |
| ASTRAZENECA | |||
| BOEHRINGER INGELHEIM GMBH | Ingelheim, Germany | 1885 | |
| BRISTOL MYERS SQUIBB | |||
| ELI LILLY & CO | |||
| GLAXOSMITHKLINE | Greater London, UK | 2000 | |
| MERCK KGAA | New Jersey, US | 1921 | Public |
| NOVARTIS AG | Basel, Switzerland | 1996 | |
| PFIZER | New York City, New York, US | 1849 | |
| ROCHE HOLDING AG | |||
| SANOFI | Paris, Ile-de-France, France | 2004 | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Petah Tikva, Israel | 1901 | Public |
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets
Email : [email protected]
Quick Links360 Quadrants is a scientific research methodology by MarketsandMarkets to understand market leaders in 6000+ micro markets